Sopharma AD-Sofia (WAR:SPH) Cyclically Adjusted FCF per Share: zł-1.76 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SPH Sopharma AD-Sofia WAR:SPH
67 GF Score
Price zł7.28
GF Value zł13.43
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Cyclically Adjusted FCF per Share?

Sopharma AD-Sofia WAR:SPH +0.55% 67 Cyclically Adjusted FCF per Share is zł-1.76 as of Mar. 2026. GuruFocus rates WAR:SPH with a GF Score™ of 67/100 and a GF Value™ of zł13.43 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sopharma AD-Sofia's adjusted free cash flow per share for the three months ended in Mar. 2026 was zł0.067. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł-1.76 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sopharma AD-Sofia was 1.00% per year. The lowest was -14.50% per year. And the median was -6.75% per year.

As of today (2026-07-15), Sopharma AD-Sofia's current stock price is zł7.28. Sopharma AD-Sofia's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was zł-1.76. Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF of today is .


Sopharma AD-Sofia  (WAR:SPH) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sopharma AD-Sofia Cyclically Adjusted FCF per Share Related Terms


Sopharma AD-Sofia Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Cyclically Adjusted FCF per Share Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.78 -0.53 -0.67 -0.68 -1.78

Sopharma AD-Sofia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.73 -0.79 -1.82 -1.78 -1.76

WAR:SPH vs MCK, CAH, COR: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Cyclically Adjusted Price-to-FCF falls into.


WAR:SPH
67GF Score
Sopharma AD-Sofia WAR:SPH
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma AD-Sofia's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.067/330.2130*330.2130
=0.067

Current CPI (Mar. 2026) = 330.2130.

Sopharma AD-Sofia Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -0.280 238.132 -0.388
201606 -0.329 241.018 -0.451
201609 -0.636 241.428 -0.870
201612 -0.209 241.432 -0.286
201703 -0.239 243.801 -0.324
201706 -0.691 244.955 -0.932
201709 -0.029 246.819 -0.039
201712 -0.415 246.524 -0.556
201803 -0.576 249.554 -0.762
201806 -1.004 251.989 -1.316
201809 -0.552 252.439 -0.722
201812 -0.587 251.233 -0.772
201903 -0.783 254.202 -1.017
201906 -0.832 256.143 -1.073
201909 -0.829 256.759 -1.066
201912 -0.440 256.974 -0.565
202006 0.000 257.797 0.000
202009 -0.756 260.280 -0.959
202012 -0.749 260.474 -0.950
202103 -0.437 264.877 -0.545
202106 -0.656 271.696 -0.797
202109 -0.513 274.310 -0.618
202112 -0.230 278.802 -0.272
202203 0.194 287.504 0.223
202206 0.113 296.311 0.126
202209 0.058 296.808 0.065
202212 0.969 296.797 1.078
202303 0.094 301.836 0.103
202306 -0.489 305.109 -0.529
202309 -1.040 307.789 -1.116
202312 1.243 306.746 1.338
202403 -2.640 312.332 -2.791
202406 1.533 314.175 1.611
202409 0.137 315.301 0.143
202412 -0.492 315.605 -0.515
202503 -0.517 319.799 -0.534
202506 -1.462 322.561 -1.497
202509 -0.030 324.800 -0.030
202512 0.156 324.054 0.159
202603 0.067 330.213 0.067

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of zł-1.76 mean?
Sopharma AD-Sofia (WAR:SPH) has a Cyclically Adjusted FCF per Share of zł-1.76 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's Cyclically Adjusted FCF per Share too high?
Sopharma AD-Sofia's current Cyclically Adjusted FCF per Share is zł-1.76. Overall, Sopharma AD-Sofia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Cyclically Adjusted FCF per Share compare to MCK and CAH?
Sopharma AD-Sofia's Cyclically Adjusted FCF per Share of zł-1.76 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current Cyclically Adjusted FCF per Share is zł-1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł13.43, compared to a current price of zł7.28 — trading 45.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is zł-1.76. Sopharma AD-Sofia's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current Cyclically Adjusted FCF per Share is zł-1.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of zł7.28 is trading 45.8% below its estimated GF Value™ of zł13.43. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for WAR:SPH:

  • Cyclically Adjusted FCF per Share: zł-1.76
  • GF Value™: zł13.43 vs. price of zł7.28 (45.8% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges 3JR:GermanySFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
67GF Score

Get the complete analysis for WAR:SPH

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł7.28
Price
zł13.43
GF Value